Summary
Examination of glucagon structure-activity relationships and their use for the development of glucagon antagonists (inhibitors) have been hampered until recently by the lack of high purity of semisynthetic glucagon analogs and inadequate study of full dose-response curves for these analogs in sensitive bioassay systems. Recently a number of highly purified glucagon fragments and semi-synthetic analogs have been prepared and their full dose-response activities examined over a wide concentration range using the hepatic membrane adenylate cyclase assay, the hepatic membrane receptor binding assay, and glycogenolytic activity in isolated rat hepatocytes. The results of these studies have enabled us to identify and dissociate the structural (and in some cases conformational) features of glucagon important for binding from those most responsible for biological activity (transduction). Key findings in these studies were the observation that: (1) the C-terminal region of glucagon is primarily of importance for hormone binding to receptors; (2) glucagon1–21 and glucagon1–6 have low potency, but are essentially fully active glucagon derivatives; and (3) highly purified glucagon2–29 ([1-des-histidine]-glucagon), [1-Nα-carbamoylhistidine]-glucagon and [1-Nα-carbamoylhistidine, 12-Nα-carbamoyllysine]-glucagon are all partial agonists.
These and other findings led us to synthesize several semisynthetic analogs of glucagon which were found to possess no intrinsic biological activity in the hepatic adenylate cyclase assay system, but which could block the effect of glucagon (competitive inhibitors) in activating adenylate cyclase in this system. Two of these highly purified analogs [1-des-histidine] [2-Nα-trinitrophenylserine, 12-homoarginine]-glucagon and [1-Nα-trinitrophenylhistidine, 12-homoarginine]-glucagon were quite potent glucagon antagonists (inhibitors) with pA2 values of 7.41 and 8.16 respectively. The latter compound has also been demonstrated to decrease dramatically blood glucose levels of diabetic animals in vivo. These results demonstrate that glucagon is a major contributor to the hyperglycemia of diabetic animals.
Examination of the known and calculated conformational properties of glucagon provide insight into the structural and conformational properties of glucagon and its analogs most responsible for its biological activity. Consideration of these features and the mechanism of glucagon action at the membrane receptor level provide a framework for further developing glucagon analogs for theoretical and therapeutic applications.
Similar content being viewed by others
References
Unger, R. H. & Orci, L., 1975. Lancet 1: 14–16; ibid., 1977. Arch. Intern. Med. 137: 482–491.
Unger, R. H., 1978. Metabolism 27: 1691–1706.
Meraldi, J.-P., Hruby, V. J. & Brewster, A.I. R., 1978. Proc. Natl. Acad. Sci. U.S.A. 74: 1373–1377.
Hruby, V. J., Deb, K. K., Yamamoto, D. M., Hadley, M. E. & Chan, W. Y., 1979. J. Med. Chem. 22: 7–12.
Hruby, V. J., Mosberg, H. I., Hadley, M. E., Chan, W. Y. & Powell, A. M., 1980. Int. J. Peptide Protein Res. 16: 372–381.
Hruby, V. J., 1981. Perspectives in Peptide Chemistry (Eberle, A., Geiger, R. & Wieland, T., eds.), pp. 207–220, S. Karger, Basel.
Hruby, V. J., 1981. Topics in Molecular Pharmacology (Burgen, A. S. V. & Roberts, G. C. K., eds.), Elsevier/North-Holland, Amsterdam. (in press).
Mosberg, H. L, Hruby, V. J. & Meraldi, J.-P., 1981. Biochemistry 20: 2822–2828.
Wünsch, E. & Wendlberger, G., 1968. Chem. Ber. 101: 3659–3663.
Protein Synthesis Group, Shanghai Institute of Biochemistry, 1975. Sci. Sin. 18: 745–768.
Fujino, M., Wakimasu, M., Shinagawa, S., Kitada, C. & Yajima, H., 1978. Chem. Pharm. Bull. 26: 539–548.
Mojsov, S. & Merrifield, R. B., 1981. Biochemistry 20: 2950–2956.
Formisano, S., Johnson, M. L. & Edelhoch, H., 1977. Proc. Natl. Acad. Sci. U.S.A. 74: 3340–3344.
Johnson, M. L., Formisano, S. & Edelhoch, H., 1978. J. Biol. Chem. 253: 1353–1356.
Johnson, R. E., Hruby, V. J. & Rupley, J. A., 1979. Biochemistry 18: 1176–1179.
Hruby, V. J., Wright, D. E., Lin, M. C. & Rodbell, M., 1976. Metabolism 25 (Suppl. 1): 1323–1325.
Hruby, V. J., Agarwal, N. S., Griffen, A., Bregman, M. D., Nugent, C. A. & Brendel, K., 1981. Biochim. Biophys. Acta 674: 383–390.
Khan, B. A., Bregman, M. D., Nugent, C. A., Hruby, V. J. & Brendel, K., 1980. Biochem. Biophys. Res. Commun. 93: 729–736.
Nooijen, W. J. & Kempen, H. J., 1979. Horm. Metab. Res. 11: 459–463.
Edelhoch, H. & Schneider, A. B., 1973. Arch. Biochem. Biophys. 157: 470–475.
Rodbell, M., Birnbaumer, L., Pohl, S. L. & Sunby, F., 1971. Proc. Natl. Acad. Sci. U.S.A. 68: 909–913.
Bregman, M. D. & Levy, D., 1977. Biochem. Biophys. Res. Commun. 78, 584–590.
Frandsen, E. K., Grønvald, F. C., Heding, L. G., Johansen, N. L., Lundt, B. F., Moody, A. J., Markussen, J. & Vølund, A., 1981. Hoppe Seylers Zeit. Physiol. Chem. 362: 665–678.
Epand, R. M. & Epand, R. F., 1972. Biochim. Biophys. Acta 285: 176–180.
Wright, D. E. & Rodbell, M., 1979. J. Biol. Chem. 254: 268–269.
Spiegel, A. M. & Bitensky, M. W., 1969. Endocrinology, 85: 638–643.
Epand, R. M. & Gray, V., 1973: Can. J. Physiol. Pharmacol. 51: 243–248.
Epand, R. M., 1980. In: Insulin: Chemistry, Structure and Function of Insulin and Related Hormones (Brandenburg, D. & Wollmer, A., eds.) pp. 363–370, W. de Gruyter, Berlin.
Cote, T. E. & Epand, R. M., 1979. Biochim. Biophys. Acta, 582: 295–306.
Wright, D. E., Hruby, V. J. & Rodbell, M., 1978. J. Biol. Chem. 253: 6338–6340.
Desbuquois, B., 1975. Eur. J. Biochem. 60, 335–347.
Rothgeb, M. T., Jones, B. N., Hayes, D. F. & Gurd, R. S., 1977. Biochemistry 16: 5813–5818.
Faloona, G. R., Marco, J. & Unger, R. H., 1970. Fed. Proc. 29: 735.
Wright, D. E., Hruby, V. J. & Rodbell, M., 1980. Biochim. Biophys. Acta 631: 49–58.
Lin, M. C., Wright, D. E., Hruby, V. J. & Rodbell, M., 1975. Biochemistry 14: 1559–1563.
Bregman, M. D. & Hruby, V. J., 1979. FEBS Letters 101: 191–194.
Sonne, O., Berg, T. & Christoffersen, T., 1978. J. Biol. Chem. 253: 3203–3210.
Grande, F., Grisolia, S. & Diederich, D., 1972. Proc. Soc. Exp. Biol. Med. 139: 855–860.
Lande, S., Gorman, R. & Bitensky, M., 1972. Endocrinology 90: 597–604.
Bromer, W. W., 1976. Metabolism 25 (Suppl. 1): 1315–1316.
Epand, R. M. & Wheeler, G. E., 1975. Biochim. Biophys. Acta 393: 236–246.
Patterson, J. M. & Bromer, W. W., 1973. J. Biol. Chem. 248: 8337–8342.
Bregman, M. D., Trivedi, D. & Hruby, V. J., 1980. J. Biol. Chem. 255: 11725–11731.
Epand, R. M., Epand, R. F. & Gray, V., 1973. Arch. Biochem. Biophys. 154: 132–136.
Ross, J. B. A., Rousslang, K. W., De Haën, C., Lavis, V. R. & Deranleau, D. A., 1979. Biochim. Biophys. Acta 576: 372–384.
Wright, D. E. & Rodbell, M., 1980. Eur. J. Biochem. 111: 11–16.
Epand, R. M. & Cote, T. E., 1976. Biochim. Biophys. Acta 453: 365–373.
Wright, D. E. & Rodbell, M., 1980. J. Biol. Chem. 255: 10884–10887.
Wright, D. E. & Rodbell, M., 1981. In: Peptides: Synthesis,Structure, Function (Rich, D. & Gross, E., eds.) Pierce Chemical Rockland, IL. (in press).
Bromer, W. W., Boucher, M. E. & Patterson, J. M.; 1973. Biochem. Biophys. Res. Commun. 53: 134–139.
Desbuquois, B., 1975. Eur. J. Biochem. 53: 569–580.
Lin, M. C., Nicosia, S. & Rodbell, M., 1976. Biochemistry 15: 4537–4540.
Rodbell, M., Krans, H. M. J., Pohl, S. L. & Birnbaumer, L., 1971. J. Biol. Chem. 246: 1861–1871.
Bregman, M. D., Hruby, V. J. & Trivedi, D., 1981. Peptides, 1980 (Brunfeldt, K., ed.), pp. 488–493, Scriptor, Copenhagen.
Abiko, T., Kumikawa, M. & Sekino, H., 1979. Chem. Pharm. Bull. 27: 2827–2831.
Hruby, V. J., Bregman, M. D., Trivedi, D., Johnson, D. & Ulichny, C., 1981. In: Peptides: Synthesis, Structure, Function (Rich, D. & Gross, E., eds.) Pierce Chemical Rockland, IL. (in press).
Wright, D. E., 1976. Ph.D. Thesis, University of Arizona, Tucson, AZ.
Epand, R. M., Rosselin, G., Hoa, D. H. B., Cote, T. E. & Laburthe, M., 1981. J. Biol. Chem. 256: 1128–1132.
Wheeler, G. E., Epand, R. M. & Barrett, D., 1974. Biochim. Biophys. Acta 372: 440–449.
Demoliou, C. D. & Epand, R. M., 1980. Biochemistry 19: 4539–4546.
Gratzer, W. B., Creeth, J. M. & Beaven, G. H., 1972. Eur. J. Biochem. 31: 505–509.
Swann, J. C. & Hammes, G. G., 1969. Biochemistry 8: 1–7.
Blanchard, M. H. & King, M. V., 1966. Biochem. Biophys. Res. Commun. 25: 298–303.
Gratzer, W. B. & Beaven, G. H., 1969. J. Biol. Chem. 244: 6675–6679.
Beaven, G. H., Gratzer, W. B. & Davies, H. G., 1969. Eur. J. Biochem. 11: 37–42.
Craig, L. C., Fisher, J. D. & King, T. P., 1965. Biochemistry 4: 311–318.
ormisano, S., Johnson, M. L. & Edelhoch, H., 1978. Biochemistry, 17: 1468–1473.
Srere, P. A. & Brooks, G. C., 1969. Arch. Biochem. Biophys. 129: 708–710.
Susaki, K., Dockerill, S., Adamiak, D. A., Tickle, I. J. & Blundell, T., 1975. Nature 257: 751–757.
King, M. V., 1965. J. Mol. Biol. 11: 549–561.
Haugen, W. P. & Lipscomb, W. N., 1969. Acta Cryst., A25, S185.
Wagman, M. E., Dobson, C. M. & Karplus, M., 1980. FEBS Letters 119: 265–270.
Gratzer, W. B., Bailey, E. & Beaven, G. H., 1967. Biochem. Biophys. Res. Commun. 28: 914–919.
Contaxis, C. C. & Epand, R. M., 1974. Can. J. Biochem. 52: 456–468.
Bornet, H. & Edelhoch, H., 1971. J. Biol. Chem. 246: 1785–1792.
Schneider, A. B. & Edelhoch, H., 1972. J. Biol. Chem. 247: 4986–4991.
Epand, R. M., Jones, A. J. S. & Schreier, S., 1977. Biochim. Biophys. Acta 491: 296–304.
Epand, R. M., Jones, A. J. S. & Sayer, B., 1977. Biochemistry 16: 4360–4368.
Jones, A. J. S., Epand, R. M. Lin, K. F., Walton, D. & Vail, W. J., 1978. Biochemistry 17: 2301–2307.
Bösch, C., Brown, L. R. & Wüthrich, K., 1980. Biochim. Biophys. Acta 603: 298–312.
Braun, W., Bösch, C., Brown, L. R., Go, N. & Wüthrich, K., 1981. Biochim. Biophys. Acta 667: 377–396.
Gratzer, W. B., Beaven, G. H., Rattle, H. W. E. & Bradbury, E. M., 1968. Eur. J. Biochem. 3: 276–283.
Edelhoch, H. & Lippoldt, R. E., 1969. J. Biol. Chem. 244: 3876–3883.
Epand, R. M., 1972. Arch. Biochem. Biophys. 148: 325–326.
Epand, R. M., 1972. J. Biol. Chem. 247: 2132–2138.
Panijpan, B. & Gratzer, W. B., 1974. Eur. J. Biochem. 45: 547–553.
Conti, C. & Forster, L. S., 1975. Biochem. Biophys. Res. Commun. 65: 1257–1263.
Ross, J. B. A., Rousslang, K. W., Deranleau, D. A. & Kwiram, A. L., 1977. Biochemistry 16: 5398–5402.
Deranleau, D. A., Ross, J. B. A., Rousslang, K. W. & Kwiram, A. L., 1978. J. Am. Chem. Soc. 100: 1913–1917.
Boesch, C., Bundi, A., Opplinger, M. & Wüthrich, K., 1978. Eur. J. Biochem. 91: 209–214.
Rothgeb, T. M., England, R. D., Jones, B. N. & Gurd, R. S., 1978. Biochemistry 17: 4564–4571.
Chou, P. Y. & Fasman, G. D., 1975. Biochemistry 14: 2536–2541.
Bregman, M. D., Cheng, S. & Levy, D., 1978. Biochim. Biophys. Acta 539: 489–495.
Blundell, T., 1979. Trends Bio. Sci., 80–83.
Rodbell, M., 1980. Nature 284: 17–22.
Ross, E. M. & Gilman, A. G., 1980. Ann. Rev. Biochem. 49: 533–564.
Hruby, V. J. & Mosberg, H. A., 1981.: Hormone Antagonists — Antihormones Agarwal M. K., (ed). Walter DeGruter, Berlin. in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hruby, V.J. Structure-conformation-activity studies of glucagon and semi-synthetic glucagon analogs. Mol Cell Biochem 44, 49–64 (1982). https://doi.org/10.1007/BF00573846
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00573846